Microviable Therapeutics will be at The Microbiome Times Partnering Forum taking place in Brussels on March 18-19th 2025. Claudio Hidalgo, PhD., cofounder and CEO, and David Ríos Covián, PhD., CTO will be attending The Microbiome [...]
Pilar Manrique, senior scientist at Microviable Therapeutics will be present at 9th Microbiome Microbiome Movement Summit taking place in Barcelona in January 28-30th 2025! The Summit explored the latest advances in microbiome science, where innovative [...]
Gijón, Spain, September 23rd 2024 – Microviable Therapeutics, a biotech company developing novel biological drugs for infectious diseases and oncology, announced today the appointment of Mehdi Chouikh Skalli as Chief Financial Officer. Mehdi Chouikh has [...]
On September 24th, we join the global community in recognizing World Cancer Research Day (WCRD)—an international movement dedicated to highlighting the critical role of cancer research in driving breakthroughs for cancer control and treatment. This [...]
David Ríos Covián, Director of Technology Development at Microviable Therapeutics, will participate in the 24th Drug Discovery Innovation Programme that will take place on 19-20 September in Barcelona. Particularly, David Rios will be present as [...]
Microviable is excited to join 24th Drug Discovery Innovation Programme that will take place on 19-20 September in Barcelona. Claudio Hidalgo, CEO at Microviable, will participate as a speaker at the event. Drug Discovery Innovation [...]
Last week we presented Microviable Therapeutics at the online investors chapter of Keiretsu Forum and we got awarded as the best company, by the pool of investors present. Keiretsu Forum is a global investment community [...]
The work, led by a joint IPLA-University of Oviedo research group and the company Microviable Therapeutics, with Susana Delgado, from IPLA-CSIC, as the responsible researcher, has managed to identify and select bacteria in the microbiota [...]
Claudio Hidalgo Cantabrana, CEO at Microviable Therapeutics, and our CBO, Rafael Permuy, will be attending Bio€quity Europe event in San Sebastián (Spain) from May 12th to 14th and May 21, 22 (virtual). On Tuesday 14th [...]
Microviable Therapeutics has signed a collaboration agreement with the Healthcare & Lifescience division of Deltalab (member of SCGP) for the international distribution of GutAlive® kit for the collection and transport of microbiota. Thanks to [...]